Bryan Truman Hunt - 17 Jan 2023 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)

Role
Chief Financial Officer
Signature
/s/ Daniel Orenstein, as Attorney-in-Fact
Issuer symbol
HCAT
Transactions as of
17 Jan 2023
Net transactions value
-$54,163
Form type
4
Filing time
19 Jan 2023, 16:00:40 UTC
Previous filing
05 Dec 2022
Next filing
24 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCAT Common Stock Sale $24,660 -2,055 -1.5% $12.00 139,291 17 Jan 2023 Direct F1
transaction HCAT Common Stock Sale $29,503 -2,354 -1.7% $12.53 136,937 18 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1.